−0.050AUD
−12.68 MAUD
5.42 MAUD
230.43 M
About MICROBA LIFE SCIENCES LIMITED
Sector
Industry
CEO
Luke Reid
Website
Headquarters
Brisbane
Founded
2017
ISIN
AU0000209868
FIGI
BBG015D3N4T1
Microba Life Sciences Ltd. analyzes the microbiome to discover novel therapeutics and develop new diagnostic tools. Its therapeutic discovery platform,analysis platform and discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The firm offers microbiome testing services via distribution partners, and is working on microbial cell therapies for inflammatory bowel disease, cancer immunotherapy and autoimmune disease. The company was founded by Gene Tyson and Philip Hugenholtz in 2017 and is headquartered in Brisbane, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MAP is 0.180 AUD — it has increased by 5.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MICROBA LIFE SCIENCES LIMITED stocks are traded under the ticker MAP.
MICROBA LIFE SCIENCES LIMITED is going to release the next earnings report on Oct 22, 2024. Keep track of upcoming events with our Earnings Calendar.
MAP stock is 5.88% volatile and has beta coefficient of 0.75. Check out the list of the most volatile stocks — is MICROBA LIFE SCIENCES LIMITED there?
One year price forecast for MICROBA LIFE SCIENCES LIMITED has a max estimate of 0.440 AUD and a min estimate of 0.350 AUD.
MICROBA LIFE SCIENCES LIMITED revenue for the last quarter amounts to 3.30 M AUD despite the estimated figure of 3.30 M AUD. In the next quarter revenue is expected to reach 4.40 M AUD.
Yes, you can track MICROBA LIFE SCIENCES LIMITED financials in yearly and quarterly reports right on TradingView.
MAP stock hasn't changed in a week, the month change is a 5.26% fall, over the last year MICROBA LIFE SCIENCES LIMITED has showed a 40.40% decrease.
MAP net income for the last quarter is −11.49 M AUD, while the quarter before that showed −7.00 M AUD of net income which accounts for −64.09% change. Track more MICROBA LIFE SCIENCES LIMITED financial stats to get the full picture.
No, MAP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROBA LIFE SCIENCES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROBA LIFE SCIENCES LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROBA LIFE SCIENCES LIMITED stock shows the sell signal. See more of MICROBA LIFE SCIENCES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MICROBA LIFE SCIENCES LIMITED future price: according to them, MAP price has a max estimate of 0.44 AUD and a min estimate of 0.35 AUD. Read a more detailed MICROBA LIFE SCIENCES LIMITED forecast: see what analysts think of MICROBA LIFE SCIENCES LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROBA LIFE SCIENCES LIMITED EBITDA is −24.62 M AUD, and current EBITDA margin is −342.89%. See more stats in MICROBA LIFE SCIENCES LIMITED financial statements.